Immune regulation therapy: inflammatory bowel disease - Enzo Biochem
Alternative Names: Alequel; Immune modulation technology - Enzo BiochemLatest Information Update: 04 Aug 2015
At a glance
- Originator Enzo Biochem
- Class Anti-inflammatories; Antigens
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Crohn's disease
Most Recent Events
- 04 Aug 2015 Phase-II development is ongoing in Israel
- 30 May 2007 Data presented at Digestive Disease Week-2007 (DDW-2007) added to the adverse events and Inflammatory Bowel Disorders therapeutic trials sections
- 30 Sep 2004 Data from a phase II trial have been added to the Inflammatory Bowel Disorders therapeutic trials section